Insilico is a Hong Kong-based biotechnology firm that offers solutions such as AI-powered drug discovery and clinical trial prediction for the life sciences industry... Read more
Insilico is a Hong Kong-based biotechnology firm that offers solutions such as AI-powered drug discovery and clinical trial prediction for the life sciences industry... Read more
2014
PublicShanghai Stock Exchange03696.HK
News
Partnership
Feb 11, 2026
Pharamceutical Technology
Insilico and CMS launch drug discovery collaborations for CNS diseases
AI
Jan 12, 2026
Marketscreener
Insilico Medicine Completes First Patient First Dose in BETHESDA: A Phase II Trial for Garutadustat (ISM5411), the Gut-restricted AI-driven PHD Inhibitor for the Treatment of Inflammatory Bowel Disease
Funding
Jan 05, 2026
aastocks.com
InSilico Medicine received undisclosed amount in IPO Funding
InSilico Medicine Competitors
1
2
3
4
5
6
7
8
9
10